Download PDF
Thromb Haemost 2010; 103(02): 257-258
DOI: 10.1160/TH10-01-0004
Editorial Focus
Schattauer GmbH

Neointima formation after vascular injury: Is it all about CD39?

Pallavi Subramanian
1   Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany
,
Andreas Schober
1   Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany
› Author Affiliations
Further Information

Publication History

Received: 04 January 2010

Accepted: 04 January 2010

Publication Date:
22 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Ip JH, Fuster V, Israel D. et al. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991; 17 6 Suppl B 77B-88B.
    PubMedGoogle Scholar
  • 2 Friedman RJ, Stemerman MB, Wenz B. et al. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re- endothelialization. J Clin Invest 1977; 60: 1191-1201.
    CrossrefPubMedGoogle Scholar
  • 3 Fingerle J, Johnson R, Clowes AW. et al. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA 1989; 86: 8412-8416.
    CrossrefPubMedGoogle Scholar
  • 4 Steele PM, Chesebro JH, Stanson AW. et al. Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-112.
    CrossrefPubMedGoogle Scholar
  • 5 Nobuyoshi M, Kimura T, Ohishi H. et al. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 1991; 17: 433-439.
    CrossrefPubMedGoogle Scholar
  • 6 Schober A, Zernecke A. Chemokines in vascular remodeling. Thromb Haemost 2007; 97: 730-737.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Schober A, Zernecke A, Liehn EA. et al. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res 2004; 95: 1125-1133.
    CrossrefPubMedGoogle Scholar
  • 8 Zernecke A, Schober A, Bot I. et al. SDF-1alpha/ CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005; 96: 784-791.
    CrossrefPubMedGoogle Scholar
  • 9 Tanguay JF, Geoffroy P, Sirois MG. et al. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb Haemost 2004; 91: 1186-1193.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Smyth SS, Reis ED, Zhang W. et al. Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury. Circulation 2001; 103: 2501-2507.
    CrossrefPubMedGoogle Scholar
  • 11 Schober A, Manka D, von Hundelshausen P. et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 2002; 106: 1523-1529.
    CrossrefPubMedGoogle Scholar
  • 12 von Hundelshausen P, Petersen F, Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 2007; 97: 704-713.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study).. The ERASER Investigators. Circulation 1999; 100: 799-806.
    CrossrefPubMedGoogle Scholar
  • 14 Schwartz L, Bourassa MG, Lesperance J. et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1714-1719.
    CrossrefPubMedGoogle Scholar
  • 15 Savage MP, Goldberg S, Bove AA. et al. Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation 1995; 92: 3194-3200.
    CrossrefPubMedGoogle Scholar
  • 16 Munnix IC, Cosemans JM, Auger JM. et al. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009; 102: 1149-1156.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009; 102: 248-257.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Drosopoulos JH, Kraemer R, Shen H. et al. Human solCD39 inhibits injury-induced development of neointimalhyperplasia. Thromb Haemost 2009; 103: 426-434.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Marcus AJ, Broekman MJ, Drosopoulos JH. et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99: 1351-1360.
    CrossrefPubMedGoogle Scholar
  • 20 Gayle RB, 3rd, Maliszewski CR, Gimpel SD. et al. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 1998; 101: 1851-1859.
    CrossrefPubMedGoogle Scholar
  • 21 Takemoto Y, Kawata H, Soeda T. et al. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis. Arterioscler Thromb Vasc Biol 2009; 29: 857-862.
    CrossrefPubMedGoogle Scholar
  • 22 Koziak K, Bojakowska M, Robson SC. et al. Over-expression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty. J Thromb Haemost 2008; 6: 1191-1197.
    CrossrefPubMedGoogle Scholar
  • 23 Behdad A, Sun X, Khalpey Z. et al. Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice. Purinergic Signal 2009; 5: 335-342.
    CrossrefPubMedGoogle Scholar
  • 24 Enjyoji K, Sevigny J, Lin Y. et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999; 5: 1010-1017.
    CrossrefPubMedGoogle Scholar
  • 25 Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008; 28: 1950-1959.
    CrossrefPubMedGoogle Scholar
  • 26 Elliott MR, Chekeni FB, Trampont PC. et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461: 282-286.
    CrossrefPubMedGoogle Scholar
  • 27 Zernecke A, Bidzhekov K, Ozuyaman B. et al. CD73/ecto-5‘-nucleotidase protects against vascular inflammation and neointima formation. Circulation 2006; 113: 2120-2127.
    CrossrefPubMedGoogle Scholar
  • 28 Yang D, Koupenova M, McCrann DJ. et al. The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci USA 2008; 105: 792-796.
    CrossrefPubMedGoogle Scholar